Encompass Health announces pricing of $500 million of senior notes due 2034 in a private offering

Rhea-AI Summary

Encompass Health (NYSE:EHC) priced a private offering of $500 million in 5.875% senior notes due 2034 at 100% of principal. Interest is payable semiannually starting Dec. 1, 2026. Closing is expected May 29, 2026, with proceeds earmarked to refinance existing debt and pay related fees.

Positive

• Refinances $400 million of 4.500% notes due 2028 at par using new 2034 notes
• Repays $100 million outstanding on senior secured revolving credit facility
• New 5.875% senior notes due 2034 extend debt maturity profile
• Notes guaranteed on a senior unsecured basis by key subsidiaries

Negative

• New 5.875% coupon exceeds 4.500% rate on redeemed 2028 notes
• Offering is private, limited to qualified institutional and certain non-U.S. investors

News Market Reaction – EHC

-0.62%

-0.62% Session close to close

In the May 15 session, EHC declined 0.62%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details a balance sheet transaction: Encompass Health priced $500 million of 5.875...

Analysis

This announcement details a balance sheet transaction: Encompass Health priced $500 million of 5.875% senior notes due 2034, with proceeds earmarked to redeem $400 million of 4.500% notes due 2028 and repay $100 million on its revolving credit facility. Investors may track future debt levels, interest expense, and how this financing supports the company’s ongoing hospital expansion and dividend commitments.

Key Figures

Senior notes size: $500 million Coupon rate: 5.875% Issue price: 100% +5 more

8 metrics

Senior notes size $500 million Aggregate principal amount of 5.875% senior notes due 2034

Coupon rate 5.875% Interest rate on senior notes due 2034

Issue price 100% Notes priced at 100% of principal amount

Interest payments Semiannual Paid June 1 and Dec. 1 each year starting Dec. 1, 2026

Redemption amount $400 million Principal of 4.500% senior notes due 2028 to be redeemed at par

Revolver repayment $100 million To repay outstanding amounts under senior secured revolving credit facility

Legacy coupon 4.500% Coupon of senior notes due 2028 being redeemed

Securities Act year 1933 Securities Act of 1933 referenced for Rule 144A and Regulation S

Historical Context

5 past events · Latest: May 11 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
May 11	New hospital plan	Positive	+3.1%	Announced plans for a new 50-bed inpatient rehabilitation hospital in Idaho.
May 07	Dividend declaration	Positive	+2.0%	Declared quarterly cash dividend of $0.19 per share with July 2026 payment.
May 05	Hospital opening	Positive	-0.1%	Opened a new 50-bed rehabilitation hospital in Concordville, Pennsylvania.
Apr 30	Q1 2026 earnings	Positive	+7.5%	Reported Q1 revenue and Adjusted EBITDA growth with modestly raised full-year guidance.
Apr 23	Conference participation	Neutral	+0.1%	Announced participation in BofA Securities 2026 Health Care Conference.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent fundamental and expansion news, including Q1 earnings and new hospitals, often coincided with positive price moves, though not uniformly.

Recent Company History

Over the past few weeks, Encompass Health reported strong Q1 2026 results with net operating revenue of $1,586.6M and Adjusted EBITDA of $348.8M, both growing solidly. The company has been expanding its hospital network, opening new 49- and 50-bed facilities and planning additional locations. A quarterly dividend of $0.19 per share was declared. Against this backdrop of growth and shareholder returns, the new senior notes offering fits into an active capital and expansion program.

Key Terms

senior notes, Rule 144A, Regulation S, private offering, +1 more

5 terms

senior notes financial

"announced the pricing of a private offering of $500 million in aggregate principal amount of 5.875% senior notes due 2034"

Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.

Rule 144A regulatory

"to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933"

Rule 144A is a regulation that makes it easier for companies to sell private bonds to large investors without going through all the usual rules that apply to public sales. It matters because it helps companies raise money more quickly and privately, often attracting big investors looking for special deals.

Regulation S regulatory

"and to certain non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act"

Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.

private offering financial

"announced the pricing of a private offering of $500 million in aggregate principal amount"

A private offering is the sale of securities—such as shares or bonds—directly to a limited group of investors rather than through public markets or a broad auction. It matters to investors because it changes who owns the company and how much cash the business has available, which can dilute existing shareholders, affect share liquidity and price discovery, and signal strategic moves or funding needs; think of it as selling a batch of goods to a few trusted customers instead of opening a shop to everyone.

senior secured revolving credit facility financial

"to repay $100 million of the outstanding amounts under the Company's senior secured revolving credit facility"

A senior secured revolving credit facility is a multi‑use bank lending line that a company can draw, repay and redraw as needed, backed by specific assets and ranked first in repayment order if the company defaults. Think of it like a collateralized credit card that gives flexible short‑term cash while lenders hold priority to recover their money; investors watch it because it affects a company’s liquidity, borrowing cost, and who gets paid first in financial distress.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BIRMINGHAM, Ala., May 14, 2026 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced the pricing of a private offering of $500 million in aggregate principal amount of 5.875% senior notes due 2034 (the "Notes") at a price of 100% of the principal amount thereof. The Company will pay interest on the Notes semiannually in arrears on June 1 and Dec. 1 of each year, beginning on Dec. 1, 2026. The Notes will be jointly and severally guaranteed on a senior unsecured basis by all of its existing and future subsidiaries that guarantee borrowings under the Company's credit agreement and other capital markets debt. This offering is expected to close on May 29, 2026, subject to customary closing conditions.

The Company intends to use the net proceeds from this offering, together with available cash on hand, to redeem at par $400 million in aggregate principal amount of its outstanding 4.500% Senior Notes due 2028, to repay $100 million of the outstanding amounts under the Company's senior secured revolving credit facility and to pay certain related fees and expenses in connection with the foregoing.

The Notes have been offered in the United States only to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), and to certain non-U.S. persons in transactions outside the United States pursuant to Regulation S under the Securities Act. The offer and any sale of the Notes and the related guarantees have not been and will not be registered under the Securities Act or any state securities laws, and the Notes may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act and applicable state securities laws.

This press release is for informational purposes only and does not constitute an offer to sell or a solicitation of an offer to buy any security and does not constitute an offer, solicitation or sale of any security in any jurisdiction in which such offer, solicitation or sale would be unlawful. This press release shall not constitute a notice of redemption with respect to the notes to be redeemed.

About Encompass Health 
Encompass Health (NYSE: EHC) is the largest owner and operator of inpatient rehabilitation hospitals in the United States. With a national footprint that includes 175 hospitals in 39 states and Puerto Rico, the Company provides high-quality, compassionate rehabilitative care for patients recovering from a major injury or illness, using advanced technology and innovative treatments to maximize recovery. Encompass Health is recognized as America's Most Awarded Leader in Inpatient Rehabilitation by Newsweek and Statista and is ranked among Fortune's World's Most Admired Companies™, Forbes' America's Best Companies and Becker's Healthcare's Top Places to Work in Healthcare. For more information, visit encompasshealth.com, or follow us on our newsroom, X, Instagram and Facebook.

From Fortune.© 2026 Fortune Media IP Limited. All rights reserved. Fortune® is a registered trademark and Fortune World's Most Admired Companies™ is a trademark of Fortune Media IP Limited and are used under license. Fortune and Fortune Media IP Limited are not affiliated with, and do not endorse products or services of, Encompass Health.

Forward-looking statements 
Statements contained in this press release which are not historical facts, such as the completion of the private offering of the Notes and the use of proceeds from the offering, are forward-looking statements. In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements concerning the matters described herein. All such estimates, projections, and forward-looking information speak only as of the date hereof, and Encompass Health undertakes no duty to publicly update or revise such forward-looking information, whether as a result of new information, future events, or otherwise. Such forward-looking statements are necessarily estimates based upon current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements as a result of a variety of factors. While it is impossible to identify all such factors, factors which could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, Encompass Health's ability to complete the offering of the Notes; potential disruptions, breaches, or other incidents affecting the proper operation, availability, or security of Encompass Health's information systems, including unauthorized access to or theft of patient, business associate, or other sensitive information; changes, delays in (including in connection with resolution of Medicare payment reviews or appeals), or suspension of reimbursement for Encompass Health's services by governmental or private payors; a significant disruption in the capital markets or economy; and other factors which may be identified from time to time in Encompass Health's SEC filings and other public announcements, including its Form 10-K for the year ended Dec. 31, 2025 and Form 10-Q for the quarter ended March 31, 2026.

Media contact:
Polly Manuel | 205.970.5912 
Media@encompasshealth.com 

Investor relations contact:
Mark Miller | 205.970.5860
Mark.Miller@encompasshealth.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/encompass-health-announces-pricing-of-500-million-of-senior-notes-due-2034-in-a-private-offering-302772871.html

SOURCE Encompass Health Corp.

FAQ

What did Encompass Health (NYSE:EHC) announce on May 14, 2026 about new senior notes?

Encompass Health announced pricing of $500 million in 5.875% senior notes due 2034 in a private offering. According to Encompass Health, the notes priced at 100% of principal and are expected to close on May 29, 2026, subject to customary conditions.

What are the key terms of Encompass Health’s 5.875% senior notes due 2034 (EHC)?

The notes are $500 million aggregate principal amount, bearing 5.875% interest and maturing in 2034. According to Encompass Health, interest is payable semiannually on June 1 and December 1, beginning December 1, 2026, and the notes are guaranteed on a senior unsecured basis by certain subsidiaries.

How will Encompass Health use the $500 million senior notes proceeds (EHC)?

Encompass Health intends to use proceeds to refinance existing debt and pay related expenses. According to Encompass Health, funds plus cash on hand will redeem $400 million of 4.500% notes due 2028, repay $100 million on its senior secured revolver, and cover associated fees.

What does the new 2034 notes offering mean for Encompass Health’s 4.500% notes due 2028?

Encompass Health plans to redeem $400 million of its outstanding 4.500% notes due 2028 at par. According to Encompass Health, this redemption will be funded using net proceeds from the 5.875% senior notes due 2034 plus available cash, subject to closing of the new offering.

Who can buy Encompass Health’s 5.875% senior notes due 2034 under Rule 144A and Regulation S?

The notes are offered privately to qualified institutional buyers in the United States under Rule 144A. According to Encompass Health, they are also offered to certain non-U.S. persons outside the United States under Regulation S, subject to applicable securities law restrictions.

Is Encompass Health’s $500 million senior notes offering (EHC) registered with the SEC?

The notes offering and related guarantees are not registered under the Securities Act or state securities laws. According to Encompass Health, the notes may not be offered or sold in the United States without registration or an applicable exemption from registration requirements.